T1	Participants 61 82	breast cancer surgery
T2	Participants 96 136	Postoperative nausea and vomiting (PONV)
T3	Participants 328 373	Sixty-eight women premedicated with midazolam
T4	Participants 1554 1625	PONV-free patients after breast cancer surgery with general anesthesia.
